These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38180429)

  • 1. Gender and Race Differences in HeartMate3 Left Ventricular Assist Device as a Bridge to Transplantation.
    Steinberg RS; Okoh AK; Wang J; Patel KJ; Gangavelli A; Nayak A; Ko YA; Gupta D; Daneshmand M; Vega JD; Morris AA
    JACC Heart Fail; 2023 Dec; ():. PubMed ID: 38180429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Outcomes After Heart Transplantation in Recipients Bridged With a HeartMate 3 Device.
    Suarez-Pierre A; Lui C; Zhou X; Crawford TC; Fraser CD; Giuliano K; Hsu S; Higgins RS; Zehr KJ; Whitman GJ; Choi CW; Kilic A
    Ann Thorac Surg; 2019 Aug; 108(2):467-473. PubMed ID: 30880137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities and outcomes of left ventricular assist device implantation as a bridge to heart transplantation.
    Okoh AK; Selevanny M; Singh S; Hirji S; Singh S; Al Obaidi N; Lee LY; Camacho M; Russo MJ
    ESC Heart Fail; 2020 Oct; 7(5):2744-2751. PubMed ID: 32627939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third-generation continuous-flow left ventricular assist devices: a comparative outcome analysis by device type.
    Mihalj M; Heinisch PP; Schober P; Wieser M; Martinelli M; de By TMMH; Schefold JC; Luedi MM; Kadner A; Carrel T; Mohacsi P; Hunziker L; Reineke D
    ESC Heart Fail; 2022 Oct; 9(5):3469-3482. PubMed ID: 35880515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of U.S. heart transplantation equity as a function of race: Observational analyses of the OPTN database.
    Cogswell R; Masotti M; Morris AA; Hart A; Murray T; Yancy C
    Lancet Reg Health Am; 2022 Sep; 13():100290. PubMed ID: 36777325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HeartMate 3 left ventricular assist device as a strategy to bridge to transplant.
    Kilcoyne MF; Huckaby LV; Hashmi Z; Witer L; Pope N; Houston BA; Inampudi C; Tedford RJ; Kilic A
    J Card Surg; 2022 Dec; 37(12):4713-4718. PubMed ID: 36321713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device Among Women and Men.
    Ramu B; Cogswell R; Ravichandran AK; Cleveland J; Mehra MR; Goldstein D; Uriel N; Dirckx N; Ahmed S; Yuzefpolskaya M
    JACC Heart Fail; 2023 Dec; 11(12):1692-1704. PubMed ID: 37831046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased frequency of transplantation and lower post-transplant survival free of re-transplantation in LVAD patients with the new heart transplant allocation system.
    Jani M; Lee S; Acharya D; Hoeksema S; Boeve T; Leacche M; Manandhar-Shrestha NK; Jovinge SV; Loyaga-Rendon RY
    Clin Transplant; 2022 Jan; 36(1):e14493. PubMed ID: 34689383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Outcomes of Centrifugal Continuous-Flow Implantable Left Ventricular Assist Devices: Heartmate 3 versus Heartware Ventricular Assist Device.
    Shin K; Cho WC; Shin N; Kim HR; Kim MS; Chung CH; Jung SH
    J Chest Surg; 2024 Mar; 57(2):184-194. PubMed ID: 38360679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Tale of Two Centrifugal-Flow Ventricular Assist Devices As Bridge to Heart Transplant.
    Alwair H; Whitehouse K; Slaughter MS; Trivedi JR
    Ann Thorac Surg; 2022 Mar; 113(3):757-762. PubMed ID: 33857496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes in Patients With HeartMate3 Versus HeartWare Ventricular Assist Device Implanted as Destination Therapy.
    Wasilewski G; Kędziora A; Wiśniowska-Śmiałek S; Tomsia P; Kaleta M; Wierzbicki K
    Transplant Proc; 2022 May; 54(4):1049-1053. PubMed ID: 35431097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right and left ventricular assist devices are an option for bridge to heart transplant.
    Barac YD; Toledano R; Jawitz OK; Schroder JN; Daneshmand MA; Patel CB; Aravot D; Milano CA
    JTCVS Open; 2022 Mar; 9():146-159. PubMed ID: 36003474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
    Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-Related Differences in Use and Outcomes of Left Ventricular Assist Devices as Bridge to Transplantation.
    DeFilippis EM; Truby LK; Garan AR; Givens RC; Takeda K; Takayama H; Naka Y; Haythe JH; Farr MA; Topkara VK
    JACC Heart Fail; 2019 Mar; 7(3):250-257. PubMed ID: 30819381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An 18-month comparison of clinical outcomes between continuous-flow left ventricular assist devices.
    Itzhaki Ben Zadok O; Ben-Avraham B; Shaul A; Hammer Y; Rubachevski V; Aravot D; Kornowski R; Ben-Gal T
    Eur J Cardiothorac Surg; 2019 Dec; 56(6):1054-1061. PubMed ID: 31566245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after heart transplantation in patients who have undergone a bridge-to-bridge strategy.
    Zhou AL; Etchill EW; Shou BL; Whitbread JJ; Barbur I; Giuliano KA; Kilic A
    JTCVS Open; 2022 Dec; 12():255-268. PubMed ID: 36590736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular assist device is protective against cardiac transplant delisting for medical unsuitability.
    Cogswell R; Duval S; John R
    Int J Cardiol; 2018 Oct; 268():51-54. PubMed ID: 29803342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De Novo Human Leukocyte Antigen Allosensitization in Heartmate 3 Versus Heartmate II Left Ventricular Assist Device Recipients.
    Jain R; Habal MV; Clerkin KJ; Latif F; Restaino SW; Zorn E; Takeda K; Naka Y; Yuzefpolskaya M; Farr MA; Colombo PC; Sayer GT; Uriel N; Topkara VK
    ASAIO J; 2022 Feb; 68(2):226-232. PubMed ID: 33883507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.